Application no. and date | 01971928.5 (espacenet) (Federated) (European Patent Register), 20010817 | Patent/reg. no. and date | DK/EP 1313511, 20051130 | Publication date | 20030528 | Priority no. and date | EP 00202939, 20000823 | EP pub. no. and date |
EP 1313511 20030528 | Effective date | | Applicant/owner | N.V. Organon, Kloosterstraat 6
5349 AB Oss, NL | Applicant ref. no. | 81292 | Inventor | SCHUTTE, Sephanus, Cornelis, Stationsweg 52
NL-6861 EJ Oosterbeek, NL, DE NIJS, Henrik, Hermelijnendreef 27
NL-5343 XC Oss, NL, KERSEMAEKERS, Wendy, Margaretha, Leeuwstraat 51
NL-6531 RB Nijmegen, NL, VAN BRUGGEN, Johann, Gerhard, Cornelis, Jan de Rooystraat 8
NL-5141 EN Waalwijk, NL | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | Opponent | | IPC Class | A61K 31/565 (2006.01) , A61K 47/44 (2006.01) , A61P 5/26 (2006.01) | Title | Testosteronesterformulering til human brug | Int. application no. | EP2001009569 | Int. publication no. | WO2002015938 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|